OrthoPediatrics [KIDS] vs Enovis [ENOV] Detailed Stock Comparison

OrthoPediatrics
NASDAQ
Loading...

Enovis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: OrthoPediatrics wins in 10 metrics, Enovis wins in 8 metrics, with 0 ties. OrthoPediatrics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | OrthoPediatrics | Enovis | Better |
---|---|---|---|
P/E Ratio (TTM) | 246.27 | -1.90 | Enovis |
Price-to-Book Ratio | 1.33 | 0.63 | Enovis |
Debt-to-Equity Ratio | 29.77 | 56.75 | OrthoPediatrics |
PEG Ratio | -18.01 | 9.00 | OrthoPediatrics |
EV/EBITDA | -38.43 | 8.41 | OrthoPediatrics |
Profit Margin (TTM) | -18.92% | -37.80% | OrthoPediatrics |
Operating Margin (TTM) | -12.58% | 2.41% | Enovis |
EBITDA Margin (TTM) | N/A | 2.41% | N/A |
Return on Equity | -11.49% | -28.25% | OrthoPediatrics |
Return on Assets (TTM) | -4.38% | 0.89% | Enovis |
Free Cash Flow (TTM) | $-41.31M | $-67.21M | OrthoPediatrics |
1-Year Return | -29.73% | -34.47% | OrthoPediatrics |
Price-to-Sales Ratio (TTM) | 2.15 | 0.74 | Enovis |
Enterprise Value | $509.83M | $3.05B | Enovis |
EV/Revenue Ratio | 2.31 | 1.39 | Enovis |
Gross Profit Margin (TTM) | 72.07% | 59.45% | OrthoPediatrics |
Revenue per Share (TTM) | $9 | $39 | Enovis |
Earnings per Share (Diluted) | $-1.80 | $-14.95 | OrthoPediatrics |
Beta (Stock Volatility) | 1.12 | 1.81 | OrthoPediatrics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
OrthoPediatrics vs Enovis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
OrthoPediatrics | -1.51% | -7.26% | -12.78% | -18.07% | -23.07% | -17.32% |
Enovis | -0.28% | 10.49% | -18.13% | -14.03% | -36.06% | -35.80% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
OrthoPediatrics | -29.73% | -65.66% | -63.63% | 0.85% | 0.85% | 0.85% |
Enovis | -34.47% | -52.47% | -52.16% | -58.10% | 33.33% | -19.39% |
Performance & Financial Health Analysis: OrthoPediatrics vs Enovis
Metric | KIDS | ENOV |
---|---|---|
Market Information | ||
Market Cap | $474.14M | $1.63B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 213,870 | 1,375,280 |
90 Day Avg. Volume | 170,243 | 1,733,377 |
Last Close | $18.91 | $28.44 |
52 Week Range | $16.59 - $33.14 | $25.47 - $49.83 |
% from 52W High | -42.94% | -42.93% |
All-Time High | $73.91 (Nov 01, 2021) | $129.72 (Jun 09, 2014) |
% from All-Time High | -74.41% | -78.08% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.16% | 0.08% |
Quarterly Earnings Growth | 0.16% | 0.08% |
Financial Health | ||
Profit Margin (TTM) | -0.19% | -0.38% |
Operating Margin (TTM) | -0.13% | 0.02% |
Return on Equity (TTM) | -0.11% | -0.28% |
Debt to Equity (MRQ) | 29.77 | 56.75 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $14.18 | $45.11 |
Cash per Share (MRQ) | $2.80 | $0.77 |
Operating Cash Flow (TTM) | $-28,884,000 | $188.06M |
Levered Free Cash Flow (TTM) | $-17,784,500 | $65.68M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: OrthoPediatrics vs Enovis
Metric | KIDS | ENOV |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 246.27 | -1.90 |
Forward P/E | -18.01 | 9.00 |
PEG Ratio | -18.01 | 9.00 |
Price to Sales (TTM) | 2.15 | 0.74 |
Price to Book (MRQ) | 1.33 | 0.63 |
Market Capitalization | ||
Market Capitalization | $474.14M | $1.63B |
Enterprise Value | $509.83M | $3.05B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.31 | 1.39 |
Enterprise to EBITDA | -38.43 | 8.41 |
Risk & Other Metrics | ||
Beta | 1.12 | 1.81 |
Book Value per Share (MRQ) | $14.18 | $45.11 |
Financial Statements Comparison: OrthoPediatrics vs Enovis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | KIDS | ENOV |
---|---|---|
Revenue/Sales | $52.41M | $558.83M |
Cost of Goods Sold | $14.15M | $226.61M |
Gross Profit | $38.26M | $332.23M |
Research & Development | $2.35M | $28.53M |
Operating Income (EBIT) | $-10.94M | $-42.91M |
EBITDA | $-4.25M | $27.14M |
Pre-Tax Income | $-10.46M | $-57.35M |
Income Tax | $196,000 | $-1.77M |
Net Income (Profit) | $-10.66M | $-55.71M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | KIDS | ENOV |
---|---|---|
Cash & Equivalents | $33.44M | $38.46M |
Total Current Assets | $232.06M | $1.22B |
Total Current Liabilities | $37.51M | $477.42M |
Long-Term Debt | $73.03M | $1.42B |
Total Shareholders Equity | $347.15M | $2.62B |
Retained Earnings | $-246.22M | $-338.99M |
Property, Plant & Equipment | N/A | $492.24M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | KIDS | ENOV |
---|---|---|
Operating Cash Flow | $-1.11M | $-1.07M |
Capital Expenditures | $-4.23M | $-43.26M |
Free Cash Flow | $-8.38M | $-44.86M |
Debt Repayment | $-126,000 | $-15.44M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | KIDS | ENOV |
---|---|---|
Shares Short | 1.12M | 7.43M |
Short Ratio | 8.93 | 4.68 |
Short % of Float | 0.07% | 0.20% |
Average Daily Volume (10 Day) | 213,870 | 1,375,280 |
Average Daily Volume (90 Day) | 170,243 | 1,733,377 |
Shares Outstanding | 24.22M | 55.88M |
Float Shares | 16.78M | 56.44M |
% Held by Insiders | 0.33% | 0.02% |
% Held by Institutions | 0.71% | 1.08% |
Dividend Analysis & Yield Comparison: OrthoPediatrics vs Enovis
Metric | KIDS | ENOV |
---|---|---|
Last 12-Month Dividend | N/A | $0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | $0.00 |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | $0.00 |
Ex-Dividend Date | N/A | N/A |